Transcription factor AP-2gamma stimulates proliferation and apoptosis and impairs differentiation in a transgenic model.

AP-2 transcription factors play pivotal roles in orchestrating embryonic development by influencing the differentiation, proliferation, and survival of cells. Furthermore, AP-2 transcription factors have been implicated in carcinogenesis, a process where the normal growth and differentiation program of cells is disturbed. To experimentally address the potential involvement of AP-2 in mammary gland tumorigenesis, we generated mice overexpressing AP-2gamma by transgenesis using the mouse mammary tumor virus-long terminal repeat as the transgene-driving promoter unit. In the mammary gland, transgene expression elicited a hyperproliferation that, however, was counterbalanced by the enhanced apoptosis of epithelial cells leading to a hypoplasia of the alveolar epithelium during late pregnancy. In addition, secretory differentiation was impaired, resulting in a lactation failure. In male transgenic mice, the seminal vesicles were sites of strong transgene expression. There the effects of AP-2gamma on proliferation and apoptosis were even more pronounced, and differentiation was impaired, too, as revealed by the absence of androgen receptor immunoreactivity. In both tissues, the mammary gland and the seminal vesicles, enhanced steady-state transcript levels of the AP-2 target gene IGFBP-5 were detected, revealing a potential mechanism of AP-2-induced apoptosis. Our results suggest a role of AP-2 transcription factors in the maintenance of a proliferative and undifferentiated state of cells, characteristics not only important during embryonic development but also in tumorigenesis.

[1]  R. Buettner,et al.  Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. , 2000, Gene.

[2]  Jian Huang,et al.  Overexpression of transcription factor AP-2alpha suppresses mammary gland growth and morphogenesis. , 2003, Developmental biology.

[3]  A. Andres,et al.  Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinase. , 2002, Journal of cell science.

[4]  K. Zerres,et al.  Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta. , 1997, Genes & development.

[5]  T. Williams,et al.  The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[6]  U. K. Laemmli,et al.  Cleavage of structural proteins during , 1970 .

[7]  N. Hynes,et al.  The biology of erbB-2/neu/HER-2 and its role in cancer. , 1994, Biochimica et biophysica acta.

[8]  P. Glazer,et al.  Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. , 1998, Cancer research.

[9]  Stella Pelengaris,et al.  c-MYC: more than just a matter of life and death , 2002, Nature Reviews Cancer.

[10]  J. Beattie,et al.  Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice. , 2002, Development.

[11]  H. Schorle,et al.  Transcription factor gene AP-2 gamma essential for early murine development. , 2002, Molecular and cellular biology.

[12]  D. Clemmons,et al.  Transcription Factor AP-2 Regulates Human Insulin-like Growth Factor Binding Protein-5 Gene Expression (*) , 1995, The Journal of Biological Chemistry.

[13]  D. Sheer,et al.  Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors. , 1996, Genomics.

[14]  D. Capello,et al.  AP-2 transcription factors in the regulation of ERBB2 gene transcription by oestrogen , 2000, Oncogene.

[15]  P. Leder,et al.  The int‐2 gene product acts as an epithelial growth factor in transgenic mice. , 1990, The EMBO journal.

[16]  R. Weigel,et al.  Identification of ERF-1 as a member of the AP2 transcription factor family. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Leder,et al.  Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice. , 1996, Oncogene.

[18]  J. Hsuan,et al.  A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. , 1996, Oncogene.

[19]  R. Tjian,et al.  Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins. , 1991, Science.

[20]  A. McMahon,et al.  Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2 , 1996, Nature.

[21]  R. Tjian,et al.  Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. , 1991, Genes & development.

[22]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[23]  Y. Hayashizaki,et al.  Cloning and Characterization of a Novel Mouse AP-2 Transcription Factor, Ap-2δ, with Unique DNA Binding and Transactivation Properties* , 2001, The Journal of Biological Chemistry.

[24]  N. Rosemblit,et al.  Regulators for the rat clusterin gene: DNA methylation and cis-acting regulatory elements. , 1994, Journal of molecular endocrinology.

[25]  R. Jaenisch,et al.  Transcription factor AP-2 essential for cranial closure and craniofacial development , 1996, Nature.

[26]  I. Ellis,et al.  Immunohistochemical analysis reveals a tumour suppressor‐like role for the transcription factor AP‐2 in invasive breast cancer , 1999, The Journal of pathology.

[27]  M. Hegen,et al.  A Subtractive Gene Expression Screen Suggests a Role of Transcription Factor AP-2α in Control of Proliferation and Differentiation* , 2002, The Journal of Biological Chemistry.